|
STK11IP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.177600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.959390E-03 |
| Normal-vs-Stage2 |
5.903800E-02 |
| Normal-vs-Stage3 |
2.015900E-04 |
| Normal-vs-Stage4 |
1.584070E-02 |
| Stage1-vs-Stage2 |
8.906200E-01 |
| Stage1-vs-Stage3 |
1.904420E-01 |
| Stage1-vs-Stage4 |
5.798000E-01 |
| Stage2-vs-Stage3 |
3.150600E-01 |
| Stage2-vs-Stage4 |
6.130400E-01 |
| Stage3-vs-Stage4 |
7.091400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.359300E-04 |
| Normal-vs-AfricanAmerican |
4.104000E-01 |
| Normal-vs-Asian |
2.947600E-02 |
| Caucasian-vs-AfricanAmerican |
2.625400E-01 |
| Caucasian-vs-Asian |
4.188200E-01 |
| AfricanAmerican-vs-Asian |
5.025600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.859000E-03 |
| Normal-vs-Female |
3.006000E-04 |
| Male-vs-Female |
6.955400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.201300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.224110E-03 |
| Normal-vs-Age(61-80Yrs) |
8.160200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.443240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.126000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.427400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.963400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.196800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.106400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.764600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.07189999992907E-07 |
| Classical-VS-Follicular |
9.345000E-01 |
| Classical-VS-Other |
1.899770E-01 |
| Classical-VS-Normal |
3.184800E-03 |
| Tall-VS-Follicular |
4.374200E-04 |
| Tall-VS-Other |
6.852600E-01 |
| Tall-VS-Normal |
3.49200002247585E-10 |
| Follicular-VS-Other |
3.431400E-01 |
| Follicular-VS-Normal |
5.849600E-02 |
| Other-VS-Normal |
7.019700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.616600E-03 |
| Normal-vs-N1 |
4.143700E-03 |
| N0-vs-N1 |
2.806000E-01 |
|
|
